Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Regencell Bioscience Holdings Ltd (RGC) Institutional Ownership & Insider Trading

35 institutions reported holding Regencell Bioscience Holdings Ltd shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · read by EquiReason

RGCRegencell Bioscience Holdings LtdFollow RGC — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
3.8B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
28 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

35 institutions held 0.3% of the shares. Across filers that reported both quarters, shares held changed +117.1%.

Increased+10New+15Decreased-5Closed-12

Largest moves, shares (millions)

Alyeska Investment Group+0.4MLegal & General Group+0.1MJane Street Group+0.1MMarex Group-0.0MGsa Capital Partners-0.0MVident Advisory-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+0.0Dec 24-0.0Mar 25+0.7Jun 25-0.1Sep 25-0.1Dec 25+0.1Mar 26+0.8Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26351+117.1%1015512
Mar 26311+18.0%51844
Dec 25171-14.2%4646
Sep 25161-8.4%4755
Jun 25131—31002
Mar 2550—1311
Dec 2430—1100
Sep 2420—1001

Regencell Bioscience Holdings Ltd — questions

Who owns Regencell Bioscience Holdings Ltd stock?
35 institutions reported Regencell Bioscience Holdings Ltd shares in 13F filings for the quarter ended 2026-06-30. The largest: GEODE CAPITAL MANAGEMENT, LLC (0.1%), Alyeska Investment Group, L.P. (0.1%), Legal & General Group Plc (0.0%).

Every figure on this page comes from Regencell Bioscience Holdings Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.